この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1998/12/21 分で読めます
Vale Chemical Co., Inc., et al.; Proposal to Withdraw Approval of 13 New Drug Applications and 1 Abbreviated New Drug Application; Opportunity for a Hearing
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on the agency's proposal to withdraw approval of 13 new drug applications (NDA's) and 1 abbreviated new drug application (ANDA). The basis for the proposal is that the sponsors have repeatedly failed to file required annual reports for these applications.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →